Genpact (NYSE:G – Get Rating) issued an update on its FY 2022 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.68-$2.74 for the period, compared to the consensus estimate of $2.63. The company issued revenue guidance of $4.32 billion-$4.37 billion, compared to the consensus revenue estimate of $4.27 billion.
Genpact Price Performance
Shares of NYSE:G traded down $1.49 during trading on Friday, reaching $46.92. 1,070,373 shares of the company traded hands, compared to its average volume of 776,222. The company’s 50 day moving average is $44.27 and its two-hundred day moving average is $43.85. The firm has a market capitalization of $8.69 billion, a PE ratio of 26.07, a PEG ratio of 1.61 and a beta of 1.36. The company has a quick ratio of 1.43, a current ratio of 1.43 and a debt-to-equity ratio of 0.68. Genpact has a 52 week low of $37.68 and a 52 week high of $54.03.
Genpact (NYSE:G – Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The business services provider reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.55 by $0.15. The company had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.07 billion. Genpact had a return on equity of 21.85% and a net margin of 8.09%. The firm’s revenue was up 10.2% compared to the same quarter last year. During the same period last year, the business posted $0.56 earnings per share. As a group, sell-side analysts predict that Genpact will post 2.37 earnings per share for the current year.
Genpact Announces Dividend
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft reduced their target price on Genpact from $55.00 to $48.00 in a research note on Friday, May 6th. Citigroup lowered their price objective on shares of Genpact from $55.00 to $52.00 and set a buy rating on the stock in a research report on Wednesday, July 20th. Finally, StockNews.com lowered Genpact from a strong-buy rating to a buy rating in a research report on Thursday, May 12th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of Moderate Buy and an average target price of $54.33.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. American Century Companies Inc. grew its position in Genpact by 57.2% in the 1st quarter. American Century Companies Inc. now owns 18,403 shares of the business services provider’s stock valued at $801,000 after buying an additional 6,699 shares in the last quarter. Bank of Montreal Can grew its holdings in shares of Genpact by 16.8% during the first quarter. Bank of Montreal Can now owns 23,398 shares of the business services provider’s stock worth $1,031,000 after purchasing an additional 3,364 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Genpact by 0.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,683,950 shares of the business services provider’s stock valued at $73,273,000 after purchasing an additional 5,331 shares in the last quarter. Sei Investments Co. increased its position in Genpact by 6.2% in the 1st quarter. Sei Investments Co. now owns 104,775 shares of the business services provider’s stock valued at $4,560,000 after buying an additional 6,151 shares in the last quarter. Finally, Aviva PLC bought a new stake in shares of Genpact in the 1st quarter worth approximately $2,219,000. Hedge funds and other institutional investors own 95.82% of the company’s stock.
Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services.
- Get a free copy of the StockNews.com research report on Genpact (G)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.